{"cveId": "CVE-2022-47376", "cwe": ["CWE-257", "CWE-522", "CWE-257", "CWE-522"], "cvss": [{"baseScore": "7.3", "version": "3.1", "Attack Vector": "Low", "Attack Complexity": "Low", "Privileges Required": "Low", "User Interaction": "None", "Scope": "Unchaged", "Confidentiality Impact": "High", "Integrity Impact": "High", "Availability Impact": "Low"}], "references": ["https://www.bd.com/en-us/about-bd/cybersecurity/bulletin/alaris-infusion-central-recoverable-password-vulnerability"], "description": ["The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installations may choose to store personal data."], "published": "2023-06-13T20:15:08.967", "state": "PUBLIC", "vendorName": ["n/a"], "productName": ["Alaris Infusion Central"], "github": {"advisories": [], "commits": [], "pocAdvisorie": null, "repo": null, "info": {}}, "pocList": []}